Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Rowe

Showing results (121-130 of 269) with videos related to

Pageof 27
Sort By:
JCI Insight|November 3, 2018
Heme scavenging reduces pulmonary endoplasmic reticulum stress, fibrosis, and emphysemaSaurabh Aggarwal, Israr Ahmad, Adam Lam, et al.
Protein Engineering, Design & Selection : PEDS|November 29, 2011
Purification of CFTR for mass spectrometry analysis: identification of palmitoylation and other post-translational modificationsMichelle McClure, Lawrence J DeLucas, Landon Wilson, et al.
American Journal of Respiratory and Critical Care Medicine|August 27, 2024
Elexacaftor/Tezacaftor/Ivacaftor Markedly Reduces <i>Aspergillus fumigatus</i> in Cystic FibrosisSarah J Morgan, David P Nichols, Windy Ni, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 23, 2011
Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54Steven M Rowe, Peter Sloane, Li Ping Tang, et al.
Chest|March 30, 2013
Acquired cystic fibrosis transmembrane conductance regulator dysfunction in the lower airways in COPDMark T Dransfield, Andrew M Wilhelm, Brian Flanagan, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2018
Ataluren, a New Therapeutic for Alpha-1 Antitrypsin-Deficient Individuals with Nonsense MutationsEmer P Reeves, Ciara A O'Dwyer, Danielle M Dunlea, et al.
International Forum of Allergy & Rhinology|June 29, 2017
Assessment of acquired mucociliary clearance defects using micro-optical coherence tomographyKiranya E Tipirneni, Jessica W Grayson, Shaoyan Zhang, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 12, 2020
Lumacaftor/ivacaftor therapy fails to increase insulin secretion in F508del/F508del CF patientsAmir Moheet, Daniel Beisang, Lin Zhang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2014
Overcoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectorsBenjamin S Schuster, Anthony J Kim, Joshua C Kays, et al.
Annals of the American Thoracic Society|July 10, 2020
Clinical Effectiveness of Lumacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for F508del-CFTR. A Clinical TrialScott D Sagel, Umer Khan, Sonya L Heltshe, et al.
Pageof 27

Showing results (121-130 of 269) with videos related to

Sort By:
Pageof 27
JCI Insight|November 3, 2018
Heme scavenging reduces pulmonary endoplasmic reticulum stress, fibrosis, and emphysemaSaurabh Aggarwal, Israr Ahmad, Adam Lam, et al.
Protein Engineering, Design & Selection : PEDS|November 29, 2011
Purification of CFTR for mass spectrometry analysis: identification of palmitoylation and other post-translational modificationsMichelle McClure, Lawrence J DeLucas, Landon Wilson, et al.
American Journal of Respiratory and Critical Care Medicine|August 27, 2024
Elexacaftor/Tezacaftor/Ivacaftor Markedly Reduces <i>Aspergillus fumigatus</i> in Cystic FibrosisSarah J Morgan, David P Nichols, Windy Ni, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 23, 2011
Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54Steven M Rowe, Peter Sloane, Li Ping Tang, et al.
Chest|March 30, 2013
Acquired cystic fibrosis transmembrane conductance regulator dysfunction in the lower airways in COPDMark T Dransfield, Andrew M Wilhelm, Brian Flanagan, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2018
Ataluren, a New Therapeutic for Alpha-1 Antitrypsin-Deficient Individuals with Nonsense MutationsEmer P Reeves, Ciara A O'Dwyer, Danielle M Dunlea, et al.
International Forum of Allergy & Rhinology|June 29, 2017
Assessment of acquired mucociliary clearance defects using micro-optical coherence tomographyKiranya E Tipirneni, Jessica W Grayson, Shaoyan Zhang, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 12, 2020
Lumacaftor/ivacaftor therapy fails to increase insulin secretion in F508del/F508del CF patientsAmir Moheet, Daniel Beisang, Lin Zhang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2014
Overcoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectorsBenjamin S Schuster, Anthony J Kim, Joshua C Kays, et al.
Annals of the American Thoracic Society|July 10, 2020
Clinical Effectiveness of Lumacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for F508del-CFTR. A Clinical TrialScott D Sagel, Umer Khan, Sonya L Heltshe, et al.
Pageof 27